Galmed Pharmaceuticals Ltd Cash Flow-to-Debt Ratio
Galmed Pharmaceuticals Ltd cash flow-to-debt ratio. Galmed Pharmaceuticals Ltd (GLMD) has a Cash Flow-to-Debt Ratio of -0.38x as of June 2026, meaning its operating cash flow of $-2.13 Million could theoretically repay 0% of its total liabilities ($5.54 Million) in one year. See Galmed Pharmaceuticals Ltd (GLMD) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Galmed Pharmaceuticals Ltd (2012–2025)
Cash flow-to-debt ratio of Galmed Pharmaceuticals Ltd from 2012 to 2025. Historical debt coverage capacity for Galmed Pharmaceuticals Ltd across 14 annual periods. Also explore GLMD net assets growth trend to track the company's year-over-year net asset growth rate.
Galmed Pharmaceuticals Ltd Cash Flow-to-Debt Ratio by Year (2012–2025)
Galmed Pharmaceuticals Ltd cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Galmed Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Galmed Pharmaceuticals Ltd (GLMD) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.22x | $-6.32 Million | $2.85 Million | ▲ +18.0% |
| 2024 | -2.71x | $-5.88 Million | $2.17 Million | ▼ -21.3% |
| 2023 | -2.23x | $-6.14 Million | $2.75 Million | ▲ +62.1% |
| 2022 | -5.90x | $-18.50 Million | $3.14 Million | ▼ -9.5% |
| 2021 | -5.39x | $-32.89 Million | $6.11 Million | ▼ -68.6% |
| 2020 | -3.19x | $-26.29 Million | $8.23 Million | ▼ -55.8% |
| 2019 | -2.05x | $-14.94 Million | $7.29 Million | ▲ +38.5% |
| 2018 | -3.33x | $-9.02 Million | $2.71 Million | ▼ -6.3% |
| 2017 | -3.14x | $-12.07 Million | $3.85 Million | ▼ -39.0% |
| 2016 | -2.26x | $-12.13 Million | $5.38 Million | ▲ +27.6% |
| 2015 | -3.12x | $-8.47 Million | $2.72 Million | ▲ +48.8% |
| 2014 | -6.09x | $-9.24 Million | $1.52 Million | ▼ -410.6% |
| 2013 | -1.19x | $-2.52 Million | $2.12 Million | ▼ -6.1% |
| 2012 | -1.12x | $-3.08 Million | $2.74 Million | — |